Premier Alternatives

Mission Bio

San Francisco, CA · Founded 2011 · Privately Held (backing)

Developer of a precision genomics platform designed to provide single-cell targeted DNA sequencing at single-base resolution. Mission Bio is based in San Francisco, CA and was founded in 2011. It was valued at $300 million at its later-stage round in May 2022, the last priced event on record. It has raised $212 million across 2 recorded rounds; the latest was a $28.4 million early-stage round in Jun 2018.

PMV mark · valuation
$300.0M
Oct 2026
Priced at
its later-stage round
May 2022
Total raised
$212.1M
Last round
Early Stage VC
Jun 2018

Mission Bio key facts

as of Oct 2026
  • Developer of a precision genomics platform designed to provide single-cell targeted DNA sequencing at single-base resolution.
  • Mission Bio is valued at approximately $300.0M as of Oct 2026, set at its later-stage round, May 2022; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $212.1M across 2 recorded rounds; the latest was Early Stage VC ($28.4M) in Jun 2018.
  • Notable investors include Alumni Ventures, StartX (US), Keiretsu Forum, Evolution VC Partners, Sand Hill Angels — 41 tracked in total.
  • Mission Bio has filed 2 Form Ds with the SEC since 2017, most recently Jul 2018 ($28.4M sold to 32 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$300.0M

Valued at $300.0M at its later-stage round, May 2022. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Mission Bio with a free account
  • ·The complete investor list: 41 names
  • ·Watch Mission Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Mission Bio funding rounds

2 rounds
Jun 2018Early Stage VC$28.4MSEC filing▮
Jun 2017Early Stage VC$13.3MSEC filing▮
Full funding history →

Mission Bio valuation

Mission Bio was valued at $300 million at its later-stage round in May 2022. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Mission Bio raised?

Mission Bio has raised $212 million in total; 2 of its rounds are on record. The largest on record was a $28.4 million early-stage round in Jun 2018.

Mission Bio has filed 2 Form Ds with the SEC since 2017, most recently in Jul 2018 ($28.4 million sold to 32 investors).

Mission Bio investors

41 investors are on record for Mission Bio, including Alumni Ventures, StartX (US), Keiretsu Forum and Evolution VC Partners. By type, the record holds 12 venture capital firms and 2 growth equity firms. The early-stage round in Jun 2018 drew 32 investors.

About Mission Bio

Developer of a precision genomics platform designed to provide single-cell targeted DNA sequencing at single-base resolution. The company's platform integrates targeted DNA sequencing with protein expression profiling at single-cell resolution, supports detection of single nucleotide and copy number variations, enables characterization of clonal heterogeneity and gene edits, and includes customizable panels and assay development services, enabling researchers and clinicians in oncology and cell therapy to uncover genetic diversity, improve therapeutic targeting, and accelerate biomarker discovery.

Sector
Healthcare
HQ
San Francisco, CA, United States
Founded
2011
Employees
76
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.